

<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xmlns:xlink="https://www.w3.org/1999/xlink">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Avicenna J Med Biotech</journal-id>
      <journal-id journal-id-type="publisher-id">arij002</journal-id>
      <journal-title-group>
        <journal-title>Avicenna Journal of Medical Biotechnology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2008-2835</issn>
      <issn pub-type="epub">2008-4625</issn>
      <publisher>
        <publisher-name>Avicenna Research Institute</publisher-name>
      </publisher>
    </journal-meta>

    <article-meta>
      <article-id pub-id-type="publisher-id">ajmb40447</article-id>
      <article-id pub-id-type="doi"></article-id>
      <article-id pub-id-type="pmid"></article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
             <subject></subject> 
        </subj-group>
        <subj-group>
            <subject></subject>
        </subj-group> 
      </article-categories>
      <title-group>
        <article-title>Comparison of Antifungal Properties of Gold, Silver, and Selenium Nanoparticles Against Amphotericin B-Resistant Candida glabrata Clinical Isolates</article-title>
      </title-group>
        <contrib-group><contrib contrib-type="author"><name><surname>Lotfali</surname><given-names>Ensieh</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Toreyhi</surname><given-names>Hossein</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Makhdoomi Sharabiani</surname><given-names>Kamyab</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Fattahi</surname><given-names>Azam</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Soheili</surname><given-names>Amirali</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Ghasemi</surname><given-names>Reza</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Keymaram</surname><given-names>Mahyar</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Rezaee</surname><given-names>Yasaman</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Iranpanah</surname><given-names>Sayna</given-names></name></contrib></contrib-group>
      <pub-date pub-type="ppub">
        <day></day>
        <month></month>
        <year></year>
      </pub-date>
      <pub-date pub-type="epub">
        <day></day>
        <month></month>
        <year></year>
      </pub-date>
      <volume>13</volume>
      <issue>1</issue>
      <fpage>47</fpage>
      <lpage>50</lpage>
      <history>
        <date date-type="received">
          <day>18</day>
          <month>4</month>
          <year>2020</year>
        </date>
        <date date-type="accepted">
          <day>16</day>
          <month>5</month>
          <year>2020</year>
        </date>
      </history>
      <abstract>
      <p>
      &lt;p&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;Background: The present study aimed to investigate the antifungal activity of Nanoparticles (NPs) against amphotericin B-resistant &lt;em&gt;Candida glabrata&lt;/em&gt; (&lt;em&gt;C. glabrata&lt;/em&gt;) strains. &lt;/span&gt;&lt;/p&gt;

&lt;p&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;Methods: Twelve resistant (&lt;em&gt;C. glabrata&lt;/em&gt;) strains were isolated from archived clinical isolates. Antifungal activity was conducted according to Clinical and Laboratory Standards Institute&amp;rsquo;s (CLSI) guidelines, document M27-A3/S4. The Scanning Electron Microscope (SEM) was used to observe the morphological changes of strains exposed to each nanoparticle. &lt;/span&gt;&lt;/p&gt;

&lt;p&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;Results: Minimum Inhibitory Concentration (MIC) of nanoparticles of all strains was in the concentration range of 0.125 to 0.5 &lt;em&gt;&amp;micro;g/Ml&lt;/em&gt;. The synthesized Ag-NPs showed superior antifungal activity against (&lt;em&gt;C. glabrata&lt;/em&gt;) compared to Se-NPs and Au-NPs. The scanning electron microscope images revealed the difference in the fungal morphology between the untreated and treated fungi with nanoparticles. &lt;/span&gt;&lt;/p&gt;

&lt;p&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;Conclusion: The Ag-NPs, followed by Se-NPs synthesized, revealed significant antifungal activity against resistance regardless of their antifungal-resistant mechanisms.&lt;/span&gt;&lt;/p&gt;

      </p>
      </abstract>
    </article-meta>
  </front>
    
</article>
